Caroline N. Smith

Also affiliated with Markey Cancer Center

Biochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A screen of FDA-approved drugs identifies inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3)”.

A screen of FDA-approved drugs identifies inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3)

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.24.098665

N/A

0DataRank · unranked

3 citations

Mark Vincent C. dela Cerna, Caroline N. Smith, Blaine G. Patty, Donghan Lee, Jessica S. Blackburn +1 more

A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)

Scientific Reports(2021)10.1038/s41598-021-89668-5

N/A

0DataRank · unranked

15 citations

Mark Vincent C. dela Cerna, Caroline N. Smith, Shilpa Sampathi, Blaine G. Patty, Donghan Lee +2 more

Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3

PLoS ONE(2023)10.1371/journal.pone.0285964

N/A

0DataRank · unranked

7 citations

Kyle C. Kihn, Zachary A. Williamson, K. Martin Chow, Louis B. Hersh, Konstantin V. Korotkov +3 more